Dr. Weikart has been with the company since its inception for 9 years and was responsible for leading the R&D efforts that resulted in the current parenteral product portfolio. Prior to joining the company he worked in Central Research at the Dow Chemical Company for 12 years in various R&D, engineering and leadership roles. Dr. Weikart earned a BS and PhD in chemical engineering from the University of Missouri-Columbia.